Monday, August 25th, 2025
Stock Profile: CODX
CODX Logo

Co-Diagnostics, Inc. (CODX)

Market: NASD | Currency: USD

Address: 2401 South Foothill Drive

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious Show more




📈 Co-Diagnostics, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for Co-Diagnostics, Inc.


DateReported EPS
2025-11-13 (estimated upcoming)-
2025-08-14-0.23
2025-05-08-0.26
2025-03-27-0.38
2024-11-07-0.33
2024-08-08-0.24
2024-05-09-0.33
2024-03-14-0.5
2023-11-09-0.22
2023-08-10-0.32
2023-05-11-0.23
2023-03-16-0.2
2022-11-10-0.08
2022-08-11-0.1
2022-05-120.25
2022-03-240.26
2021-11-110.38
2021-08-120.33
2021-05-130.26
2021-03-250.45
2020-11-160.53
2020-08-130.43
2020-05-14-0.05
2020-03-30-0.09
2019-11-12-0.1




📰 Related News & Research


No related articles found for "codiagnostics inc".